This statistic depicts the top biologic drugs by share of total drug costs within select Canadian public drug plans in 2017/2018. Top listed biologic drug was Remicade with a 4.3 percent share of total drug costs that year.
Top biologic drugs by share of total drug costs within select Canadian public drug plans in 2017/2018*
* Select public drug plans include Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Prince Edward Island, British Columbia, Newfoundland and Labrador, and the Non-Insured Health Benefit plan.
This analysis only includes data for beneficiaries that met their deductible and received public reimbursement.
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
Statista Accounts:
Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Premium Account
Your perfect start with Statista
Instant access to 1m statistics
Download in XLS, PDF & PNG format
Detailed references
$59$39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Statista Accounts:
Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
PMPRB. (September 6, 2019). Top biologic drugs by share of total drug costs within select Canadian public drug plans in 2017/2018* [Graph]. In Statista. Retrieved April 09, 2020, from https://www.statista.com/statistics/487533/biologic-drugs-by-share-of-total-drug-costs-in-canadian-public-plans/
PMPRB. "Top biologic drugs by share of total drug costs within select Canadian public drug plans in 2017/2018*." Chart. September 6, 2019. Statista. Accessed April 09, 2020. https://www.statista.com/statistics/487533/biologic-drugs-by-share-of-total-drug-costs-in-canadian-public-plans/
PMPRB. (2019). Top biologic drugs by share of total drug costs within select Canadian public drug plans in 2017/2018*. Statista. Statista Inc.. Accessed: April 09, 2020. https://www.statista.com/statistics/487533/biologic-drugs-by-share-of-total-drug-costs-in-canadian-public-plans/
PMPRB. "Top Biologic Drugs by Share of Total Drug Costs within Select Canadian Public Drug Plans in 2017/2018*." Statista, Statista Inc., 6 Sep 2019, https://www.statista.com/statistics/487533/biologic-drugs-by-share-of-total-drug-costs-in-canadian-public-plans/
PMPRB, Top biologic drugs by share of total drug costs within select Canadian public drug plans in 2017/2018* Statista, https://www.statista.com/statistics/487533/biologic-drugs-by-share-of-total-drug-costs-in-canadian-public-plans/ (last visited April 09, 2020)
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.
